The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
Toll-like receptors: Activation, signalling and transcriptional modulation
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pattern Recognition Receptors and Inflammation
Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
Medzhitov, R., Preston-Hurlburt, P., & Janeway, C. A. (1997) · Nature · doi:10.1038/41131 · Cited by 5,590
Lemaitre, B., Nicolas, E., Michaut, L., Reichhart, J.-M., & Hoffmann, J. A. (1996) · Cell · doi:10.1016/s0092-8674(00)80172-5 · Cited by 4,043
Toll-like receptors and their crosstalk with other innate receptors in infection and immunity
Kawai, T., & Akira, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.006 · Cited by 3,658 · cited 11×
“Our understanding of modern day innate immunity began with the discovery of the TLRs, and in a relatively short time, we have gained a huge understanding of the proteins and mechanisms involved in the signalling pathways downstream of these receptors and their crosstalk with other TLRs or PRRs. Studies that have solve…”
BackgroundInfluentialRole of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway
Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H., Takeuchi, O., Sugiyama, M., Okabe, M., Takeda, K., et al. (2003) · Science · doi:10.1126/science.1087262 · Cited by 3,235
Sterile inflammation: sensing and reacting to damage
Chen, G. Y., & Nuñez, G. (2010) · Nature Reviews Immunology · doi:10.1038/nri2873 · Cited by 3,051
Bauernfeind, F. G., Horvath, G., Stutz, A., Alnemri, E. S., MacDonald, K., Speert, D., Fernandes-Alnemri, T., Wu, J., Monks, B. G., Fitzgerald, K. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901363 · Cited by 2,959
Activation and regulation of the inflammasomes
Latz, E., Xiao, T. S., & Stutz, A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3452 · Cited by 2,884
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
O'Neill, L. A. J., & Bowie, A. G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2079 · Cited by 2,667
Macrophages in atherosclerosis: a dynamic balance
Moore, K. J., Sheedy, F. J., & Fisher, E. A. (2013) · Nature reviews. Immunology · doi:10.1038/nri3520 · Cited by 2,559
Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation
Xue, J., Schmidt, S. V., Sander, J., Draffehn, A., Krebs, W., Quester, I., De Nardo, D., Gohel, T. D., Emde, M., Schmidleithner, L., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.006 · Cited by 2,210
Unresponsiveness of MyD88-Deficient Mice to Endotoxin
Kawai, T., Adachi, O., Ogawa, T., Takeda, K., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80086-2 · Cited by 2,076
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis
Khera, A. V., Cuchel, M., de la Llera-Moya, M., Rodrigues, A., Burke, M. F., Jafri, K., French, B. C., Phillips, J. A., Mucksavage, M. L., Wilensky, R. L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1001689 · Cited by 1,943 · cited 1×
“Functional HDL inversely correlates with incidences of coronary artery disease [133–135]; however, the ability of HDL to dampen specific TLR responses via ATF3 suggests that HDL-based therapeutics could also be beneficial in treating a range of chronic inflammatory diseases beyond atherosclerosis.”
BackgroundThe history of toll-like receptors - redefining innate immunity
O'Neill, L. A. J., Golenbock, D., & Bowie, A. G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3446 · Cited by 1,765 · cited 1×
“The functional roles of many inflammatory mediators have long been known; however, the pathways leading to their production have only become clearer since the relatively recent emergence of the innate immune system, which began following the discovery of TLRs [7].”
BackgroundInfluentialStewart, C. R., Stuart, L. M., Wilkinson, K., van Gils, J. M., Deng, J., Halle, A., Rayner, K. J., Boyer, L., Zhong, R., Frazier, W. A., et al. (2010) · Nature Immunology · doi:10.1038/ni.1836 · Cited by 1,513 · cited 2×
“This is perhaps best exemplified by the recognition of oxidised low-density lipoproteins and Amyloid-b by the scavenger receptor CD36, which initiates assembly of a trimeric complex composed of CD36 and a TLR4/TLR6 heterodimer [30].”
BackgroundOncogenically active MYD88 mutations in human lymphoma
Ngo, V. N., Young, R. M., Schmitz, R., Jhavar, S., Xiao, W., Lim, K.-H., Kohlhammer, H., Xu, W., Yang, Y., Zhao, H., et al. (2011) · Nature · doi:10.1038/nature09671 · Cited by 1,512
Antiinflammatory Properties of HDL
Barter, P. J., Nicholls, S., Rye, K.-A., Anantharamaiah, G. M., Navab, M., & Fogelman, A. M. (2004) · Circulation Research · doi:10.1161/01.res.0000146094.59640.13 · Cited by 1,394
HDL cholesterol efflux capacity and incident cardiovascular events
Rohatgi, A., Khera, A., Berry, J. D., Givens, E. G., Ayers, C. R., Wedin, K. E., Neeland, I. J., Yuhanna, I. S., Rader, D. R., de Lemos, J. A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409065 · Cited by 1,390 · cited 1×
“Functional HDL inversely correlates with incidences of coronary artery disease [133–135]; however, the ability of HDL to dampen specific TLR responses via ATF3 suggests that HDL-based therapeutics could also be beneficial in treating a range of chronic inflammatory diseases beyond atherosclerosis.”
BackgroundCooperation of Toll-like receptor signals in innate immune defence
Trinchieri, G., & Sher, A. (2007) · Nature Reviews Immunology · doi:10.1038/nri2038 · Cited by 1,364
Unified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
Lu, A., Magupalli, V. G., Ruan, J., Yin, Q., Atianand, M. K., Vos, M. R., Schröder, G. F., Fitzgerald, K. A., Wu, H., & Egelman, E. H. (2014) · Cell · doi:10.1016/j.cell.2014.02.008 · Cited by 1,353
Cutting Edge: Role of Toll-Like Receptor 1 in Mediating Immune Response to Microbial Lipoproteins
Takeuchi, O., Sato, S., Horiuchi, T., Hoshino, K., Takeda, K., Dong, Z., Modlin, R. L., & Akira, S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.10 · Cited by 1,329
Pyogenic Bacterial Infections in Humans with MyD88 Deficiency
von Bernuth, H., Picard, C., Jin, Z., Pankla, R., Xiao, H., Ku, C.-L., Chrabieh, M., Mustapha, I. B., Ghandil, P., Camcioglu, Y., et al. (2008) · Science · doi:10.1126/science.1158298 · Cited by 1,287
IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling
Kobayashi, K., Hernandez, L. D., Galán, J. E., Janeway, C. A., Medzhitov, R., & Flavell, R. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00827-9 · Cited by 1,286
Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction
Fitzgerald, K. A., Palsson-McDermott, E. M., Bowie, A. G., Jefferies, C. A., Mansell, A. S., Brady, G., Brint, E., Dunne, A., Gray, P., Harte, M. T., et al. (2001) · Nature · doi:10.1038/35092578 · Cited by 1,256
TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β
Kagan, J. C., Su, T., Horng, T., Chow, A., Akira, S., & Medzhitov, R. (2008) · Nature Immunology · doi:10.1038/ni1569 · Cited by 1,253
Discrimination of bacterial lipoproteins by Toll-like receptor 6
Takeuchi, O., Kawai, T., Mühlradt, P. F., Morr, M., Radolf, J. D., Zychlinsky, A., Takeda, K., & Akira, S. (2001) · International Immunology · doi:10.1093/intimm/13.7.933 · Cited by 1,232
Yamamoto, M., Sato, S., Mori, K., Hoshino, K., Takeuchi, O., Takeda, K., & Akira, S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.12.6668 · Cited by 1,227
Oshiumi, H., Matsumoto, M., Funami, K., Akazawa, T., & Seya, T. (2003) · Nature Immunology · doi:10.1038/ni886 · Cited by 1,207
MyD88: An Adapter That Recruits IRAK to the IL-1 Receptor Complex
Wesche, H., Henzel, W. J., Shillinglaw, W., Li, S., & Cao, Z. (1997) · Immunity · doi:10.1016/s1074-7613(00)80402-1 · Cited by 1,117
Helical Assembly in the MyD88-IRAK4-IRAK2 Complex in TLR/IL-1R Signalling
Lin, S.-C., Lo, Y.-C., & Wu, H. (2010) · Nature · doi:10.1038/nature09121 · Cited by 1,111 · cited 2×
“The crystal structure of the Myddosome was subsequently solved revealing a tower shaped complex of four layers: two layers comprising two and four MyD88 DDs, respectively, followed by a third layer of four IRAK4 DDs and a final layer of four IRAK2 DDs (or likely IRAK1 under physiological conditions) that assemble as a…”
BackgroundYamamoto, M., Sato, S., Hemmi, H., Uematsu, S., Hoshino, K., Kaisho, T., Takeuchi, O., Takeda, K., & Akira, S. (2003) · Nature Immunology · doi:10.1038/ni986 · Cited by 1,051
Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors
Takaoka, A., Yanai, H., Kondo, S., Duncan, G., Negishi, H., Mizutani, T., Kano, S.-I., Honda, K., Ohba, Y., Mak, T. W., et al. (2005) · Nature · doi:10.1038/nature03308 · Cited by 1,039
Transcriptional control of the inflammatory response
Medzhitov, R., & Horng, T. (2009) · Nature Reviews Immunology · doi:10.1038/nri2634 · Cited by 1,035
Fernandes-Alnemri, T., Wu, J., Yu, J.-W., Datta, P., Miller, B., Jankowski, W., Rosenberg, S., Zhang, J., & Alnemri, E. S. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402194 · Cited by 1,026
CD14 Controls the LPS-Induced Endocytosis of Toll-like Receptor 4
Zanoni, I., Ostuni, R., Marek, L. R., Barresi, S., Barbalat, R., Barton, G. M., Granucci, F., & Kagan, J. C. (2011) · Cell · doi:10.1016/j.cell.2011.09.051 · Cited by 997
Type I Interferon in Systemic Lupus Erythematosus and Other Autoimmune Diseases
Banchereau, J., & Pascual, V. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.010 · Cited by 963
Sheedy, F. J., Grebe, A., Rayner, K. J., Kalantari, P., Ramkhelawon, B., Carpenter, S. B., Becker, C. E., Ediriweera, H. N., Mullick, A. E., Golenbock, D. T., et al. (2013) · Nature Immunology · doi:10.1038/ni.2639 · Cited by 935
Molecular Basis of NF-κB Signaling
Napetschnig, J., & Wu, H. (2013) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-083012-130338 · Cited by 933
HDL and cardiovascular disease
Rader, D. J., & Hovingh, G. K. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61217-4 · Cited by 870 · cited 1×
“Functional HDL inversely correlates with incidences of coronary artery disease [133–135]; however, the ability of HDL to dampen specific TLR responses via ATF3 suggests that HDL-based therapeutics could also be beneficial in treating a range of chronic inflammatory diseases beyond atherosclerosis.”
BackgroundMicroRNAs: the fine-tuners of Toll-like receptor signalling
O'Neill, L. A., Sheedy, F. J., & McCoy, C. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2957 · Cited by 856
Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4
Suzuki, N., Suzuki, S., Duncan, G. S., Millar, D. G., Wada, T., Mirtsos, C., Takada, H., Wakeham, A., Itie, A., Li, S., et al. (2002) · Nature · doi:10.1038/nature736 · Cited by 853
Phosphoinositide-Mediated Adaptor Recruitment Controls Toll-like Receptor Signaling
Kagan, J. C., & Medzhitov, R. (2006) · Cell · doi:10.1016/j.cell.2006.03.047 · Cited by 847
Assembly and localization of Toll-like receptor signalling complexes
Gay, N. J., Symmons, M. F., Gangloff, M., & Bryant, C. E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3713 · Cited by 832
Pyogenic Bacterial Infections in Humans with IRAK-4 Deficiency
Picard, C., Puel, A., Bonnet, M., Ku, C.-L., Bustamante, J., Yang, K., Soudais, C., Dupuis, S., Feinberg, J., Fieschi, C., et al. (2003) · Science · doi:10.1126/science.1081902 · Cited by 826
The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors
Horng, T., Barton, G. M., Flavell, R. A., & Medzhitov, R. (2002) · Nature · doi:10.1038/nature01180 · Cited by 809
Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4
Gilchrist, M., Thorsson, V., Li, B., Rust, A. G., Korb, M., Kennedy, K., Hai, T., Bolouri, H., & Aderem, A. (2006) · Nature · doi:10.1038/nature04768 · Cited by 803
Michel, T., Reichhart, J.-M., Hoffmann, J. A., & Royet, J. (2001) · Nature · doi:10.1038/414756a · Cited by 796
Baroja-Mazo, A., Martín-Sánchez, F., Gomez, A. I., Martínez, C. M., Amores-Iniesta, J., Compan, V., Barberà-Cremades, M., Yagüe, J., Ruiz-Ortiz, E., Antón, J., et al. (2014) · Nature Immunology · doi:10.1038/ni.2919 · Cited by 790 · cited 1×
“Interestingly, the release of cellular content following pyroptosis includes the preformed prion-like ASC speck that can propagate inflammation by acting as a stable signalling platform for continued caspase-1 activation within the extracellular space [86,87].”
BackgroundThe adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation
Franklin, B. S., Bossaller, L., De Nardo, D., Ratter, J. M., Stutz, A., Engels, G., Brenker, C., Nordhoff, M., Mirandola, S. R., Al-Amoudi, A., et al. (2014) · Nature Immunology · doi:10.1038/ni.2913 · Cited by 773 · cited 1×
“Interestingly, the release of cellular content following pyroptosis includes the preformed prion-like ASC speck that can propagate inflammation by acting as a stable signalling platform for continued caspase-1 activation within the extracellular space [86,87].”
BackgroundNon-transcriptional Priming and Deubiquitination Regulate NLRP3 Inflammasome Activation
Juliana, C., Fernandes-Alnemri, T., Kang, S., Farias, A., Qin, F., & Alnemri, E. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.407130 · Cited by 773
TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity
Creagh, E. M., & O’Neill, L. A. J. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.06.003 · Cited by 762
IRAK-4: A novel member of the IRAK family with the properties of an IRAK-kinase
Li, S., Strelow, A., Fontana, E. J., & Wesche, H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082100399 · Cited by 711
Sato, S., Sugiyama, M., Yamamoto, M., Watanabe, Y., Kawai, T., Takeda, K., & Akira, S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.4304 · Cited by 710
A cell biological view of Toll-like receptor function: regulation through compartmentalization
Barton, G. M., & Kagan, J. C. (2009) · Nature Reviews Immunology · doi:10.1038/nri2587 · Cited by 709
Structure and Function of Toll Receptors and Their Ligands
Gay, N. J., & Gangloff, M. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.060305.151318 · Cited by 667
MyD88, an Adapter Protein Involved in Interleukin-1 Signaling
Burns, K., Martinon, F., Esslinger, C., Pahl, H., Schneider, P., Bodmer, J.-L., Di Marco, F., French, L., & Tschopp, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.12203 · Cited by 631
Anderson, K. V., Bokla, L., & Nüsslein-Volhard, C. (1985) · Cell · doi:10.1016/0092-8674(85)90275-2 · Cited by 621
The interleukin‐1 receptor/Toll‐like receptor superfamily: 10 years of progress
O'Neill, L. A. J. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00701.x · Cited by 616
Bafica, A., Scanga, C. A., Feng, C. G., Leifer, C., Cheever, A., & Sher, A. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051782 · Cited by 601 · cited 1×
“tuberculosis and Trypanosoma cruzi [90,91].”
Tabeta, K., Hoebe, K., Janssen, E. M., Du, X., Georgel, P., Crozat, K., Mudd, S., Mann, N., Sovath, S., Goode, J., et al. (2006) · Nature Immunology · doi:10.1038/ni1297 · Cited by 600
Triantafilou, M., Miyake, K., Golenbock, D. T., & Triantafilou, K. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.12.2603 · Cited by 581
Cai, X., Chen, J., Xu, H., Liu, S., Jiang, Q.-X., Halfmann, R., & Chen, Z. J. (2014) · Cell · doi:10.1016/j.cell.2014.01.063 · Cited by 567
Carty, M., Goodbody, R., Schröder, M., Stack, J., Moynagh, P. N., & Bowie, A. G. (2006) · Nature Immunology · doi:10.1038/ni1382 · Cited by 539
Honda, K., Yanai, H., Mizutani, T., Negishi, H., Shimada, N., Suzuki, N., Ohba, Y., Takaoka, A., Yeh, W.-C., & Taniguchi, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406933101 · Cited by 525
Burns, K., Janssens, S., Brissoni, B., Olivos, N., Beyaert, R., & Tschopp, J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021790 · Cited by 512
Uematsu, S., Sato, S., Yamamoto, M., Hirotani, T., Kato, H., Takeshita, F., Matsuda, M., Coban, C., Ishii, K. J., Kawai, T., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042372 · Cited by 488
In vivo protection against endotoxin by plasma high density lipoprotein.
Levine, D. M., Parker, T. S., Donnelly, T. M., Walsh, A., & Rubin, A. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.12040 · Cited by 485
Ligand-induced conformational changes allosterically activate Toll-like receptor 9
Latz, E., Verma, A., Visintin, A., Gong, M., Sirois, C. M., Klein, D. C. G., Monks, B. G., McKnight, C. J., Lamphier, M. S., Duprex, W. P., et al. (2007) · Nature Immunology · doi:10.1038/ni1479 · Cited by 465
Newly described pattern recognition receptors team up against intracellular pathogens
Broz, P., & Monack, D. M. (2013) · Nature Reviews Immunology · doi:10.1038/nri3479 · Cited by 462
De Nardo, D., Labzin, L. I., Kono, H., Seki, R., Schmidt, S. V., Beyer, M., Xu, D., Zimmer, S., Lahrmann, C., Schildberg, F. A., et al. (2014) · Nature Immunology · doi:10.1038/ni.2784 · Cited by 462
Self-citationIRAK-M Is a Novel Member of the Pelle/Interleukin-1 Receptor-associated Kinase (IRAK) Family
Wesche, H., Gao, X., Li, X., Kirschning, C. J., Stark, G. R., & Cao, Z. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19403 · Cited by 446
Sequential control of Toll-like receptor–dependent responses by IRAK1 and IRAK2
Kawagoe, T., Sato, S., Matsushita, K., Kato, H., Matsui, K., Kumagai, Y., Saitoh, T., Kawai, T., Takeuchi, O., & Akira, S. (2008) · Nature Immunology · doi:10.1038/ni.1606 · Cited by 442
NLRP3 inflammasomes link inflammation and metabolic disease
De Nardo, D., & Latz, E. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.05.004 · Cited by 425
Dissecting negative regulation of Toll-like receptor signaling
Kondo, T., Kawai, T., & Akira, S. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.05.002 · Cited by 419
Brinkmann, M. M., Spooner, E., Hoebe, K., Beutler, B., Ploegh, H. L., & Kim, Y.-M. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200612056 · Cited by 411
Synergy and Cross-Tolerance Between Toll-Like Receptor (TLR) 2- and TLR4-Mediated Signaling Pathways
Sato, S., Nomura, F., Kawai, T., Takeuchi, O., Mühlradt, P. F., Takeda, K., & Akira, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.7096 · Cited by 401
Motshwene, P. G., Moncrieffe, M. C., Grossmann, J. G., Kao, C., Ayaluru, M., Sandercock, A. M., Robinson, C. V., Latz, E., & Gay, N. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.022392 · Cited by 391
The molecular structure of the Toll-like receptor 3 ligand-binding domain
Bell, J. K., Botos, I., Hall, P. R., Askins, J., Shiloach, J., Segal, D. M., & Davies, D. R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505077102 · Cited by 380
Genetic variation in Toll-like receptors and disease susceptibility
Netea, M. G., Wijmenga, C., & O'Neill, L. A. J. (2012) · Nature Immunology · doi:10.1038/ni.2284 · Cited by 376
ATF3 transcription factor and its emerging roles in immunity and cancer
Thompson, M. R., Xu, D., & Williams, B. R. G. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0520-x · Cited by 359
Structural Reorganization of the Toll-Like Receptor 8 Dimer Induced by Agonistic Ligands
Tanji, H., Ohto, U., Shibata, T., Miyake, K., & Shimizu, T. (2013) · Science · doi:10.1126/science.1229159 · Cited by 348
Bagchi, A., Herrup, E. A., Warren, H. S., Trigilio, J., Shin, H.-S., Valentine, C., & Hellman, J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.2.1164 · Cited by 347
Toll-Like Receptor Pathways in Autoimmune Diseases
Chen, J.-Q., Szodoray, P., & Zeher, M. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8473-z · Cited by 315 · cited 1×
“Indeed, besides microbial infections, TLRs and other PRRs are implicated in a multitude of chronic inflammatory diseases, including atherosclerosis, rheumatoid arthritis, gout and autoimmune disease [15–18].”
BackgroundGohda, J., Matsumura, T., & Inoue, J.-I. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.2913 · Cited by 312
The interleukin-1 receptor-associated kinases: Critical regulators of innate immune signalling
Flannery, S., & Bowie, A. G. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.020 · Cited by 312
Localisation and trafficking of Toll-like receptors: an important mode of regulation
McGettrick, A. F., & O’Neill, L. A. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.12.002 · Cited by 307
SMOCs: supramolecular organizing centres that control innate immunity
Kagan, J. C., Magupalli, V. G., & Wu, H. (2014) · Nature Reviews Immunology · doi:10.1038/nri3757 · Cited by 305
HAI, T., WOLFORD, C. C., & CHANG, Y.-S. (2010) · Gene Expression · doi:10.3727/105221610x12819686555015 · Cited by 301
Dobrovolskaia, M. A., Medvedev, A. E., Thomas, K. E., Cuesta, N., Toshchakov, V., Ren, T., Cody, M. J., Michalek, S. M., Rice, N. R., & Vogel, S. N. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.508 · Cited by 300
HDL in innate and adaptive immunity
Catapano, A. L., Pirillo, A., Bonacina, F., & Norata, G. D. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu150 · Cited by 299
Bafica, A., Santiago, H. C., Goldszmid, R., Ropert, C., Gazzinelli, R. T., & Sher, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.3515 · Cited by 296
The Inflammasomes and Autoinflammatory Syndromes
Broderick, L., De Nardo, D., Franklin, B. S., Hoffman, H. M., & Latz, E. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040431 · Cited by 295
Self-citationIRAK-1 bypasses priming and directly links TLRs to rapid NLRP3 inflammasome activation
Lin, K.-M., Hu, W., Troutman, T. D., Jennings, M., Brewer, T., Li, X., Nanda, S., Cohen, P., Thomas, J. A., & Pasare, C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320294111 · Cited by 288
Rowe, D. C., McGettrick, A. F., Latz, E., Monks, B. G., Gay, N. J., Yamamoto, M., Akira, S., O’Neill, L. A., Fitzgerald, K. A., & Golenbock, D. T. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510041103 · Cited by 286
Impaired Cytokine Signaling in Mice Lacking the IL-1 Receptor-Associated Kinase
Thomas, J. A., Allen, J. L., Tsen, M., Dubnicoff, T., Danao, J., Liao, X. C., Cao, Z., & Wasserman, S. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.978 · Cited by 280
Wurfel, M. M., Hailman, E., & Wright, S. D. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1743 · Cited by 267
Medvedev, A. E., Lentschat, A., Kuhns, D. B., Blanco, J. C. G., Salkowski, C., Zhang, S., Arditi, M., Gallin, J. I., & Vogel, S. N. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030701 · Cited by 261
Cutting Edge: TLR Signaling Licenses IRAK1 for Rapid Activation of the NLRP3 Inflammasome
Fernandes-Alnemri, T., Kang, S., Anderson, C., Sagara, J., Fitzgerald, K. A., & Alnemri, E. S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301681 · Cited by 237
IRAK-mediated Translocation of TRAF6 and TAB2 in the Interleukin-1-induced Activation of NFκB
Qian, Y., Commane, M., Ninomiya-Tsuji, J., Matsumoto, K., & Li, X. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102262200 · Cited by 222
Bonham, K. S., Orzalli, M. H., Hayashi, K., Wolf, A. I., Glanemann, C., Weninger, W., Iwasaki, A., Knipe, D. M., & Kagan, J. C. (2014) · Cell · doi:10.1016/j.cell.2014.01.019 · Cited by 220
Andrade, W. A., Souza, M. D. C., Ramos-Martinez, E., Nagpal, K., Dutra, M. S., Melo, M. B., Bartholomeu, D. C., Ghosh, S., Golenbock, D. T., & Gazzinelli, R. T. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2012.12.003 · Cited by 216
Negative Regulation of TLR-Signaling Pathways by Activating Transcription Factor-3
Whitmore, M. M., Iparraguirre, A., Kubelka, L., Weninger, W., Hai, T., & Williams, B. R. G. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3622 · Cited by 214
Dunne, A., Ejdebäck, M., Ludidi, P. L., O'Neill, L. A. J., & Gay, N. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301742200 · Cited by 210
Targeting protein kinases for the development of anti-inflammatory drugs
Cohen, P. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.01.015 · Cited by 207
New Insights into Mechanisms Controlling the NLRP3 Inflammasome and Its Role in Lung Disease
De Nardo, D., De Nardo, C. M., & Latz, E. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.09.007 · Cited by 205
Self-citationRole of adapters in Toll-like receptor signalling
Akira, S., Yamamoto, M., & Takeda, K. (2003) · Biochemical Society Transactions · doi:10.1042/bst0310637 · Cited by 187
Toll-like receptors as molecular switches
Gay, N. J., Gangloff, M., & Weber, A. N. R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1916 · Cited by 183
Kawagoe, T., Sato, S., Jung, A., Yamamoto, M., Matsui, K., Kato, H., Uematsu, S., Takeuchi, O., & Akira, S. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061523 · Cited by 183
Experimental and natural infections in My D 88‐ and IRAK‐4‐deficient mice and humans
von Bernuth, H., Picard, C., Puel, A., & Casanova, J. (2012) · European Journal of Immunology · doi:10.1002/eji.201242683 · Cited by 181
Rhyasen, G. W., & Starczynowski, D. T. (2015) · British Journal of Cancer · doi:10.1038/bjc.2014.513 · Cited by 173
What the Myddosome structure tells us about the initiation of innate immunity
Gay, N. J., Gangloff, M., & O’Neill, L. A. J. (2011) · Trends in Immunology · doi:10.1016/j.it.2010.12.005 · Cited by 173
Restraint of inflammatory signaling by interdependent strata of negative regulatory pathways
Murray, P. J., & Smale, S. T. (2012) · Nature Immunology · doi:10.1038/ni.2391 · Cited by 170 · cited 1×
“Negative regulators of TLRs have recently been comprehensively reviewed by others [107–110]; here, I will instead focus on the regulation of transcriptional responses downstream of TLR activation by activating transcription factor 3 (ATF3).”
BackgroundThe interplay between the innate immune system and the microbiota
Thaiss, C. A., Levy, M., Suez, J., & Elinav, E. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.10.016 · Cited by 167
Negative regulatory approaches to the attenuation of Toll-like receptor signaling
Anwar, M. A., Basith, S., & Choi, S. (2013) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.28 · Cited by 161
The modification of biophysical and endotoxic properties of bacterial lipopolysaccharides by serum.
Ulevitch, R. J., & Johnston, A. R. (1978) · Journal of Clinical Investigation · doi:10.1172/jci109252 · Cited by 152
Valkov, E., Stamp, A. L., DiMaio, F., Baker, D. A., Verstak, B., Roversi, P., Kellie, S., Sweet, M. J., Mansell, A. S., Gay, N. J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104780108 · Cited by 148
IRAK4 Dimerization and trans -Autophosphorylation Are Induced by Myddosome Assembly
Ferrao, R., Zhou, H., Shan, Y., Liu, Q., Li, Q., Shaw, D. E., Li, X., & Wu, H. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.08.006 · Cited by 148
Helical assembly in the death domain (DD) superfamily
Ferrao, R., & Wu, H. (2012) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2012.02.006 · Cited by 147
Glucocorticoids suppress inflammation via the upregulation of negative regulator IRAK-M
Miyata, M., Lee, J.-Y., Susuki-Miyata, S., Wang, W. Y., Xu, H., Kai, H., Kobayashi, K. S., Flavell, R. A., & Li, J. (2015) · Nature Communications · doi:10.1038/ncomms7062 · Cited by 142
IRAK‐M mediates Toll‐like receptor/IL‐1R‐induced NFκB activation and cytokine production
Zhou, H., Yu, M., Fukuda, K., Im, J., Yao, P., Cui, W., Bulek, K., Zepp, J. A., Wan, Y., Kim, T. W., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.2 · Cited by 142
Nardo, D. D., Nardo, C. M. D., Nguyen, T. U., Hamilton, J. A., & Scholz, G. M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901031 · Cited by 110
Chaudhary, D., Robinson, S. D., & Romero, D. L. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5016044 · Cited by 109
Activating transcription factor 3 (ATF3) represses the expression of CCL4 in murine macrophages
Khuu, C. H., Barrozo, R. M., Hai, T., & Weinstein, S. L. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.08.006 · Cited by 106
Augmentation of Therapeutic Responses in Melanoma by Inhibition of IRAK-1,-4
Srivastava, R., Geng, D., Liu, Y., Zheng, L., Li, Z., Joseph, M. A., McKenna, C., Bansal, N., Ochoa, A. C., & Dávila, E. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0337 · Cited by 80
IRAK4 in TLR/IL‐1R signaling: Possible clinical applications
Li, X. (2008) · European Journal of Immunology · doi:10.1002/eji.200838161 · Cited by 79
ATF3 is a novel regulator of mouse neutrophil migration
Boespflug, N. D., Kumar, S., McAlees, J. W., Phelan, J. D., Grimes, H. L., Hoebe, K. H. N., Hai, T., Filippi, M., & Karp, C. L. (2014) · Blood · doi:10.1182/blood-2013-06-510909 · Cited by 74
Two Human MYD88 Variants, S34Y and R98C, Interfere with MyD88-IRAK4-Myddosome Assembly
George, J., Motshwene, P. G., Wang, H., Kubarenko, A. V., Rautanen, A., Mills, T. C., Hill, A. V. S., Gay, N. J., & Weber, A. N. R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.159996 · Cited by 66
Ichinohe, T. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.118 · Cited by 61
Song, K. W., Talamás, F. X., Suttmann, R. T., Olson, P. S., Barnett, J. W., Lee, S. W., Thompson, K., Jin, S., Hekmat-Nejad, M., Cai, T. Z., et al. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2008.12.012 · Cited by 61
Chang, Z. L. (2009) · Biology of the Cell · doi:10.1042/bc20080227 · Cited by 56
Prion-like polymerization as a signaling mechanism
Cai, X., & Chen, Z. J. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.10.003 · Cited by 45
Cai, X., Xu, Y., Kim, Y., Loureiro, J., & Huang, Q. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302411 · Cited by 44
Pelka, K., Phulphagar, K. M., Zimmermann, J., Stahl, R., Schmid-Burgk, J. L., Schmidt, T., Spille, J.-H., Labzin, L. I., Agrawal, S., Kandimalla, E. R., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301886 · Cited by 38
Down-regulation of IRAK-4 is a component of LPS- and CpG DNA-induced tolerance in macrophages
Nardo, D. D., Nguyen, T. U., Hamilton, J. A., & Scholz, G. M. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.10.009 · Cited by 36
Toll-Like Receptors, Their Ligands, and Atherosclerosis
Hodgkinson, C. P., & Ye, S. (2011) · The Scientific World JOURNAL · doi:10.1100/tsw.2011.36 · Cited by 35
Optimization of transcription factor binding map accuracy utilizing knockout-mouse models
Krebs, W., Schmidt, S. V., Goren, A., Nardo, D. D., Labzin, L. I., Bovier, A., Ulas, T., Theis, H., Kraut, M., Latz, E., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1078 · Cited by 27
Cited by
Pattern recognition receptors in health and diseases
Li, D., & Wu, M. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00687-0 · Cited by 1,787
Verkhratsky, A., & Nedergaard, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00042.2016 · Cited by 1,678
Innate immunity in diabetic kidney disease
Tang, S. C. W., & Yiu, W. H. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0234-4 · Cited by 596
Innate immunity in diabetes and diabetic nephropathy
Wada, J., & Makino, H. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.175 · Cited by 427
Immune Dysfunction and Risk of Infection in Chronic Kidney Disease
Syed-Ahmed, M., & Narayanan, M. (2019) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2019.01.004 · Cited by 411
Metadata
- Authors
- De Nardo, D.
- Venue
- Cytokine
- Publisher
- Elsevier BV
- Published
- 2015-08
- Volume
- 74
- Issue
- 2
- Pages
- 181-189
- ISSN
- 1043-4666 (ISSN-L)
- OpenAlex
- W1965658052
- Cited by
- 457
- References
- 138
- FWCI
- 21.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.